nobiletin has been researched along with Acute Myelogenous Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, PY; Chen, YT; Gao, WY; Wu, MJ; Yen, JH | 1 |
| Chang, JL; Chen, HY; Chien, MH; Chow, JM; Hsiao, PC; Lai, GM; Lee, LM; Lee, WJ; Tan, P; Yang, SF | 1 |
2 other study(ies) available for nobiletin and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Nobiletin Down-Regulates c-KIT Gene Expression and Exerts Antileukemic Effects on Human Acute Myeloid Leukemia Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Flavones; Humans; Leukemia, Myeloid, Acute; Promoter Regions, Genetic; Proto-Oncogene Mas; Proto-Oncogene Proteins c-kit | 2018 |
Nobiletin suppresses the proliferation and induces apoptosis involving MAPKs and caspase-8/-9/-3 signals in human acute myeloid leukemia cells.
Topics: Antineoplastic Agents; Antioxidants; Apoptosis; Caspase 3; Caspase 8; Caspase 9; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Flavones; Humans; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinases; Signal Transduction | 2014 |